BPA Call HT001419A0035-HT001423F0038
Award Date
3/1/23
Potential Completion Date
2/28/24
Potential Value
$74K
Federal Agency
Defense Health Agency
Awardee
Cell Marque Corp
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $55,168.14, was issued by the Defense Health Agency (DHA) to Cell Marque Corporation, a manufacturer and supplier of antibodies and reagents for immunohistochemistry. The award is a firm fixed-price Blanket Purchase Agreement (BPA) call for the delivery of various reagents and peripheral consumables, such as the Marque Corp BOB 1 and CD1a antibody reagents. This BPA contract, with a total potential value of $650,000, serves as an indefinite delivery vehicle...
The U.S. Defense Health Agency awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to Cell Marque Corp, a manufacturer and supplier of antibodies and reagents for immunohistochemistry. The $90,000 contract is for the provision of "REAGENTS AND PERIPHERAL CONSUMABLES" to support medical research and diagnostic testing services at military medical facilities. This order is part of a larger $650,000 single-award BPA that the Defense Health Agency has in place with Cell...
This federal contract award is a BPA (Blanket Purchase Agreement) call placed by the Navy Bureau of Medicine and Surgery, a component of the Department of Defense, with Cell Marque Corp. for the delivery of antibody reagents and associated laboratory supplies used in immunohistochemistry testing at military medical facilities. The contract has a ceiling value of $20,000.00 and was awarded on a Firm Fixed Price basis on September 20, 2015, with a period of performance through September 30,...
This firm fixed price blanket purchase agreement (BPA) call contract was awarded by the Defense Health Agency to Cell Marque Corporation on November 6, 2019 for the delivery of antibodies and kits for the agency's Pathology Department. With a potential value of $78,882.58, the contract has a completion date of November 5, 2020 and does not have a set-aside designation. Cell Marque Corporation will deliver the requested products from their facility located in Bethesda, Maryland to support the...
<p>Cell Marque Corporation was awarded a $100,000 firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency to provide reagents and supplies. The contract has a period of performance through November 2021 for products to be delivered to locations in Bethesda, Maryland. No set-aside provisions were applied to this award made by the agency to support its medical research and healthcare programs.</p>
This is a federal contract award from the Defense Health Agency to Biocare Medical LLC, a for-profit limited liability company and manufacturer of medical equipment and supplies, specifically specializing in immunohistochemistry (IHC) products and automated medical technologies. The contract, valued at $225,275.28, is for the procurement of antibodies and is a firm fixed-price purchase order with a period of performance ending on March 24, 2027. The contract is not set aside for any specific...
This federal contract award is for the provision of REAGENTS AND SUPPLIES to the Defense Health Agency. The contract, which is a Blanket Purchase Agreement (BPA) call, was awarded to Cancer Diagnostics, Inc. (CDI), a for-profit manufacturer of goods for the anatomic pathology and histology market. The award has a firm fixed price pricing type and does not have a set-aside designation. The potential value of the contract is $150,000.00, and the period of performance runs from the award date of...
This is a firm-fixed-price Blanket Purchase Agreement (BPA) call issued by the Defense Health Agency (DHA) to Biocare Medical LLC, a manufacturer of immunohistochemistry (IHC) products. The $25,000 call is for the procurement of specialized reagents and peripheral consumables, including those for Treponema pallidum, smoothelin, and amyloid testing. This is an existing single-award BPA between Biocare Medical and the Department of the Army Medical Command, with a potential total value of $187,800...
The Department of the Army Medical Command awarded a blanket purchase agreement (BPA) call contract to Biocare Medical LLC under an existing BPA vehicle. The $25,178.80 firm-fixed-price contract is for the delivery of immunohistochemistry antibodies with a period of performance concluding on June 9, 2021. Awarded without a set-aside designation, the contract supports the agency's medical research and operations at Fort Liberty, North Carolina through the provision of specialized antibody...
The Defense Health Agency awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $1,438,405.31 contract is for the delivery of immunohistochemistry antibodies, special stain reagents, and routine hematoxylin and eosin (H&E) reagents, with a period of performance through September 28, 2023. This award was...